The global Afutuzumab market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Afutuzumab, more commonly known as obinutuzumab is a humanized type II monoclonal antibody against CD20 (coded for by MS4A1 for the treatment of Chronic lymphocytic leukemia, CLL. It may have more direct antibody-dependent cell-mediated cytotoxicity and possibly more direct cytotoxicity than previously available type I antibodies such as rituximab and ofatumumab which have more complement-dependent cytotoxicity.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Patent segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Afutuzumab include BOC Sciences, Carbosynth, Roche Group, TargetMol Chemicals, Wonda Science, Absin Bioscience, Chunchuang (Wuhan) Technology, Hubei Kele Fine Chemical, Jiangxi Ruiweier Biotechnology, Qingdao Jieshikang Biotechnology, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Afutuzumab manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Afutuzumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Afutuzumab. This report contains market size and forecasts of Afutuzumab in global, including the following market information:
Global Afutuzumab market revenue, 2020-2025, 2026-2032, ($ millions)
Global Afutuzumab market sales, 2020-2025, 2026-2032, (Kg)
Global top five Afutuzumab companies in 2024 (%)
Total Market by Segment:
Global Afutuzumab market, by Type, 2020-2025, 2026-2032 ($ millions) & (Kg)
Global Afutuzumab market segment percentages, by Type, 2024 (%)
Patent
Generic
Global Afutuzumab market, by Application, 2020-2025, 2026-2032 ($ Millions) & (Kg)
Global Afutuzumab market segment percentages, by Application, 2024 (%)
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Global Afutuzumab market, by region and country, 2020-2025, 2026-2032 ($ millions) & (Kg)
Global Afutuzumab market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Afutuzumab revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Afutuzumab revenues share in global market, 2024 (%)
Key companies Afutuzumab sales in global market, 2020-2025 (estimated), (Kg)
Key companies Afutuzumab sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
BOC Sciences
Carbosynth
Roche Group
TargetMol Chemicals
Wonda Science
Absin Bioscience
Chunchuang (Wuhan) Technology
Hubei Kele Fine Chemical
Jiangxi Ruiweier Biotechnology
Qingdao Jieshikang Biotechnology
Shanghai Biochempartner
Shanghai Macklin Biochemical
Shanghai Qiming Biotechnology
Shanghai Saimai Biotechnology
Shanghai Shize Biological Technology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Tianmen Hengchang Chemical
Wuhan Sunrise Technology Development
Wuhan Yingnuo Pharmaceutical Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Afutuzumab, market overview.
Chapter 2: Global Afutuzumab market size in revenue and volume.
Chapter 3: Detailed analysis of Afutuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Afutuzumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Afutuzumab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Afutuzumab Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Afutuzumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Afutuzumab Overall Market Size
2.1 Global Afutuzumab Market Size: 2024 VS 2032
2.2 Global Afutuzumab Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Afutuzumab Sales: 2020-2032
3 Company Landscape
3.1 Top Afutuzumab Players in Global Market
3.2 Top Global Afutuzumab Companies Ranked by Revenue
3.3 Global Afutuzumab Revenue by Companies
3.4 Global Afutuzumab Sales by Companies
3.5 Global Afutuzumab Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Afutuzumab Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Afutuzumab Product Type
3.8 Tier 1, Tier 2, and Tier 3 Afutuzumab Players in Global Market
3.8.1 List of Global Tier 1 Afutuzumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Afutuzumab Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Afutuzumab Market Size Markets, 2024 & 2032
4.1.2 Patent
4.1.3 Generic
4.2 Segment by Type - Global Afutuzumab Revenue & Forecasts
4.2.1 Segment by Type - Global Afutuzumab Revenue, 2020-2025
4.2.2 Segment by Type - Global Afutuzumab Revenue, 2026-2032
4.2.3 Segment by Type - Global Afutuzumab Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Afutuzumab Sales & Forecasts
4.3.1 Segment by Type - Global Afutuzumab Sales, 2020-2025
4.3.2 Segment by Type - Global Afutuzumab Sales, 2026-2032
4.3.3 Segment by Type - Global Afutuzumab Sales Market Share, 2020-2032
4.4 Segment by Type - Global Afutuzumab Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Afutuzumab Market Size, 2024 & 2032
5.1.2 Chronic Lymphocytic Leukemia
5.1.3 Follicular Lymphoma
5.2 Segment by Application - Global Afutuzumab Revenue & Forecasts
5.2.1 Segment by Application - Global Afutuzumab Revenue, 2020-2025
5.2.2 Segment by Application - Global Afutuzumab Revenue, 2026-2032
5.2.3 Segment by Application - Global Afutuzumab Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Afutuzumab Sales & Forecasts
5.3.1 Segment by Application - Global Afutuzumab Sales, 2020-2025
5.3.2 Segment by Application - Global Afutuzumab Sales, 2026-2032
5.3.3 Segment by Application - Global Afutuzumab Sales Market Share, 2020-2032
5.4 Segment by Application - Global Afutuzumab Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Afutuzumab Market Size, 2024 & 2032
6.2 By Region - Global Afutuzumab Revenue & Forecasts
6.2.1 By Region - Global Afutuzumab Revenue, 2020-2025
6.2.2 By Region - Global Afutuzumab Revenue, 2026-2032
6.2.3 By Region - Global Afutuzumab Revenue Market Share, 2020-2032
6.3 By Region - Global Afutuzumab Sales & Forecasts
6.3.1 By Region - Global Afutuzumab Sales, 2020-2025
6.3.2 By Region - Global Afutuzumab Sales, 2026-2032
6.3.3 By Region - Global Afutuzumab Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Afutuzumab Revenue, 2020-2032
6.4.2 By Country - North America Afutuzumab Sales, 2020-2032
6.4.3 United States Afutuzumab Market Size, 2020-2032
6.4.4 Canada Afutuzumab Market Size, 2020-2032
6.4.5 Mexico Afutuzumab Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Afutuzumab Revenue, 2020-2032
6.5.2 By Country - Europe Afutuzumab Sales, 2020-2032
6.5.3 Germany Afutuzumab Market Size, 2020-2032
6.5.4 France Afutuzumab Market Size, 2020-2032
6.5.5 U.K. Afutuzumab Market Size, 2020-2032
6.5.6 Italy Afutuzumab Market Size, 2020-2032
6.5.7 Russia Afutuzumab Market Size, 2020-2032
6.5.8 Nordic Countries Afutuzumab Market Size, 2020-2032
6.5.9 Benelux Afutuzumab Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Afutuzumab Revenue, 2020-2032
6.6.2 By Region - Asia Afutuzumab Sales, 2020-2032
6.6.3 China Afutuzumab Market Size, 2020-2032
6.6.4 Japan Afutuzumab Market Size, 2020-2032
6.6.5 South Korea Afutuzumab Market Size, 2020-2032
6.6.6 Southeast Asia Afutuzumab Market Size, 2020-2032
6.6.7 India Afutuzumab Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Afutuzumab Revenue, 2020-2032
6.7.2 By Country - South America Afutuzumab Sales, 2020-2032
6.7.3 Brazil Afutuzumab Market Size, 2020-2032
6.7.4 Argentina Afutuzumab Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Afutuzumab Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Afutuzumab Sales, 2020-2032
6.8.3 Turkey Afutuzumab Market Size, 2020-2032
6.8.4 Israel Afutuzumab Market Size, 2020-2032
6.8.5 Saudi Arabia Afutuzumab Market Size, 2020-2032
6.8.6 UAE Afutuzumab Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 BOC Sciences
7.1.1 BOC Sciences Company Summary
7.1.2 BOC Sciences Business Overview
7.1.3 BOC Sciences Afutuzumab Major Product Offerings
7.1.4 BOC Sciences Afutuzumab Sales and Revenue in Global (2020-2025)
7.1.5 BOC Sciences Key News & Latest Developments
7.2 Carbosynth
7.2.1 Carbosynth Company Summary
7.2.2 Carbosynth Business Overview
7.2.3 Carbosynth Afutuzumab Major Product Offerings
7.2.4 Carbosynth Afutuzumab Sales and Revenue in Global (2020-2025)
7.2.5 Carbosynth Key News & Latest Developments
7.3 Roche Group
7.3.1 Roche Group Company Summary
7.3.2 Roche Group Business Overview
7.3.3 Roche Group Afutuzumab Major Product Offerings
7.3.4 Roche Group Afutuzumab Sales and Revenue in Global (2020-2025)
7.3.5 Roche Group Key News & Latest Developments
7.4 TargetMol Chemicals
7.4.1 TargetMol Chemicals Company Summary
7.4.2 TargetMol Chemicals Business Overview
7.4.3 TargetMol Chemicals Afutuzumab Major Product Offerings
7.4.4 TargetMol Chemicals Afutuzumab Sales and Revenue in Global (2020-2025)
7.4.5 TargetMol Chemicals Key News & Latest Developments
7.5 Wonda Science
7.5.1 Wonda Science Company Summary
7.5.2 Wonda Science Business Overview
7.5.3 Wonda Science Afutuzumab Major Product Offerings
7.5.4 Wonda Science Afutuzumab Sales and Revenue in Global (2020-2025)
7.5.5 Wonda Science Key News & Latest Developments
7.6 Absin Bioscience
7.6.1 Absin Bioscience Company Summary
7.6.2 Absin Bioscience Business Overview
7.6.3 Absin Bioscience Afutuzumab Major Product Offerings
7.6.4 Absin Bioscience Afutuzumab Sales and Revenue in Global (2020-2025)
7.6.5 Absin Bioscience Key News & Latest Developments
7.7 Chunchuang (Wuhan) Technology
7.7.1 Chunchuang (Wuhan) Technology Company Summary
7.7.2 Chunchuang (Wuhan) Technology Business Overview
7.7.3 Chunchuang (Wuhan) Technology Afutuzumab Major Product Offerings
7.7.4 Chunchuang (Wuhan) Technology Afutuzumab Sales and Revenue in Global (2020-2025)
7.7.5 Chunchuang (Wuhan) Technology Key News & Latest Developments
7.8 Hubei Kele Fine Chemical
7.8.1 Hubei Kele Fine Chemical Company Summary
7.8.2 Hubei Kele Fine Chemical Business Overview
7.8.3 Hubei Kele Fine Chemical Afutuzumab Major Product Offerings
7.8.4 Hubei Kele Fine Chemical Afutuzumab Sales and Revenue in Global (2020-2025)
7.8.5 Hubei Kele Fine Chemical Key News & Latest Developments
7.9 Jiangxi Ruiweier Biotechnology
7.9.1 Jiangxi Ruiweier Biotechnology Company Summary
7.9.2 Jiangxi Ruiweier Biotechnology Business Overview
7.9.3 Jiangxi Ruiweier Biotechnology Afutuzumab Major Product Offerings
7.9.4 Jiangxi Ruiweier Biotechnology Afutuzumab Sales and Revenue in Global (2020-2025)
7.9.5 Jiangxi Ruiweier Biotechnology Key News & Latest Developments
7.10 Qingdao Jieshikang Biotechnology
7.10.1 Qingdao Jieshikang Biotechnology Company Summary
7.10.2 Qingdao Jieshikang Biotechnology Business Overview
7.10.3 Qingdao Jieshikang Biotechnology Afutuzumab Major Product Offerings
7.10.4 Qingdao Jieshikang Biotechnology Afutuzumab Sales and Revenue in Global (2020-2025)
7.10.5 Qingdao Jieshikang Biotechnology Key News & Latest Developments
7.11 Shanghai Biochempartner
7.11.1 Shanghai Biochempartner Company Summary
7.11.2 Shanghai Biochempartner Business Overview
7.11.3 Shanghai Biochempartner Afutuzumab Major Product Offerings
7.11.4 Shanghai Biochempartner Afutuzumab Sales and Revenue in Global (2020-2025)
7.11.5 Shanghai Biochempartner Key News & Latest Developments
7.12 Shanghai Macklin Biochemical
7.12.1 Shanghai Macklin Biochemical Company Summary
7.12.2 Shanghai Macklin Biochemical Business Overview
7.12.3 Shanghai Macklin Biochemical Afutuzumab Major Product Offerings
7.12.4 Shanghai Macklin Biochemical Afutuzumab Sales and Revenue in Global (2020-2025)
7.12.5 Shanghai Macklin Biochemical Key News & Latest Developments
7.13 Shanghai Qiming Biotechnology
7.13.1 Shanghai Qiming Biotechnology Company Summary
7.13.2 Shanghai Qiming Biotechnology Business Overview
7.13.3 Shanghai Qiming Biotechnology Afutuzumab Major Product Offerings
7.13.4 Shanghai Qiming Biotechnology Afutuzumab Sales and Revenue in Global (2020-2025)
7.13.5 Shanghai Qiming Biotechnology Key News & Latest Developments
7.14 Shanghai Saimai Biotechnology
7.14.1 Shanghai Saimai Biotechnology Company Summary
7.14.2 Shanghai Saimai Biotechnology Business Overview
7.14.3 Shanghai Saimai Biotechnology Afutuzumab Major Product Offerings
7.14.4 Shanghai Saimai Biotechnology Afutuzumab Sales and Revenue in Global (2020-2025)
7.14.5 Shanghai Saimai Biotechnology Key News & Latest Developments
7.15 Shanghai Shize Biological Technology
7.15.1 Shanghai Shize Biological Technology Company Summary
7.15.2 Shanghai Shize Biological Technology Business Overview
7.15.3 Shanghai Shize Biological Technology Afutuzumab Major Product Offerings
7.15.4 Shanghai Shize Biological Technology Afutuzumab Sales and Revenue in Global (2020-2025)
7.15.5 Shanghai Shize Biological Technology Key News & Latest Developments
7.16 Shanghai Yifei Biotechnology
7.16.1 Shanghai Yifei Biotechnology Company Summary
7.16.2 Shanghai Yifei Biotechnology Business Overview
7.16.3 Shanghai Yifei Biotechnology Afutuzumab Major Product Offerings
7.16.4 Shanghai Yifei Biotechnology Afutuzumab Sales and Revenue in Global (2020-2025)
7.16.5 Shanghai Yifei Biotechnology Key News & Latest Developments
7.17 Shanghai Yu'ang Chemical
7.17.1 Shanghai Yu'ang Chemical Company Summary
7.17.2 Shanghai Yu'ang Chemical Business Overview
7.17.3 Shanghai Yu'ang Chemical Afutuzumab Major Product Offerings
7.17.4 Shanghai Yu'ang Chemical Afutuzumab Sales and Revenue in Global (2020-2025)
7.17.5 Shanghai Yu'ang Chemical Key News & Latest Developments
7.18 Tianmen Hengchang Chemical
7.18.1 Tianmen Hengchang Chemical Company Summary
7.18.2 Tianmen Hengchang Chemical Business Overview
7.18.3 Tianmen Hengchang Chemical Afutuzumab Major Product Offerings
7.18.4 Tianmen Hengchang Chemical Afutuzumab Sales and Revenue in Global (2020-2025)
7.18.5 Tianmen Hengchang Chemical Key News & Latest Developments
7.19 Wuhan Sunrise Technology Development
7.19.1 Wuhan Sunrise Technology Development Company Summary
7.19.2 Wuhan Sunrise Technology Development Business Overview
7.19.3 Wuhan Sunrise Technology Development Afutuzumab Major Product Offerings
7.19.4 Wuhan Sunrise Technology Development Afutuzumab Sales and Revenue in Global (2020-2025)
7.19.5 Wuhan Sunrise Technology Development Key News & Latest Developments
7.20 Wuhan Yingnuo Pharmaceutical Technology
7.20.1 Wuhan Yingnuo Pharmaceutical Technology Company Summary
7.20.2 Wuhan Yingnuo Pharmaceutical Technology Business Overview
7.20.3 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Major Product Offerings
7.20.4 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales and Revenue in Global (2020-2025)
7.20.5 Wuhan Yingnuo Pharmaceutical Technology Key News & Latest Developments
8 Global Afutuzumab Production Capacity, Analysis
8.1 Global Afutuzumab Production Capacity, 2020-2032
8.2 Afutuzumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Afutuzumab Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Afutuzumab Supply Chain Analysis
10.1 Afutuzumab Industry Value Chain
10.2 Afutuzumab Upstream Market
10.3 Afutuzumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Afutuzumab Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Afutuzumab in Global Market
Table 2. Top Afutuzumab Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Afutuzumab Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Afutuzumab Revenue Share by Companies, 2020-2025
Table 5. Global Afutuzumab Sales by Companies, (Kg), 2020-2025
Table 6. Global Afutuzumab Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Afutuzumab Price (2020-2025) & (US$/Kg)
Table 8. Global Manufacturers Afutuzumab Product Type
Table 9. List of Global Tier 1 Afutuzumab Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Afutuzumab Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Afutuzumab Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Afutuzumab Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Afutuzumab Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Afutuzumab Sales (Kg), 2020-2025
Table 15. Segment by Type - Global Afutuzumab Sales (Kg), 2026-2032
Table 16. Segment by Application � Global Afutuzumab Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Afutuzumab Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Afutuzumab Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Afutuzumab Sales, (Kg), 2020-2025
Table 20. Segment by Application - Global Afutuzumab Sales, (Kg), 2026-2032
Table 21. By Region � Global Afutuzumab Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Afutuzumab Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Afutuzumab Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Afutuzumab Sales, (Kg), 2020-2025
Table 25. By Region - Global Afutuzumab Sales, (Kg), 2026-2032
Table 26. By Country - North America Afutuzumab Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Afutuzumab Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Afutuzumab Sales, (Kg), 2020-2025
Table 29. By Country - North America Afutuzumab Sales, (Kg), 2026-2032
Table 30. By Country - Europe Afutuzumab Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Afutuzumab Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Afutuzumab Sales, (Kg), 2020-2025
Table 33. By Country - Europe Afutuzumab Sales, (Kg), 2026-2032
Table 34. By Region - Asia Afutuzumab Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Afutuzumab Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Afutuzumab Sales, (Kg), 2020-2025
Table 37. By Region - Asia Afutuzumab Sales, (Kg), 2026-2032
Table 38. By Country - South America Afutuzumab Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Afutuzumab Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Afutuzumab Sales, (Kg), 2020-2025
Table 41. By Country - South America Afutuzumab Sales, (Kg), 2026-2032
Table 42. By Country - Middle East & Africa Afutuzumab Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Afutuzumab Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Afutuzumab Sales, (Kg), 2020-2025
Table 45. By Country - Middle East & Africa Afutuzumab Sales, (Kg), 2026-2032
Table 46. BOC Sciences Company Summary
Table 47. BOC Sciences Afutuzumab Product Offerings
Table 48. BOC Sciences Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 49. BOC Sciences Key News & Latest Developments
Table 50. Carbosynth Company Summary
Table 51. Carbosynth Afutuzumab Product Offerings
Table 52. Carbosynth Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 53. Carbosynth Key News & Latest Developments
Table 54. Roche Group Company Summary
Table 55. Roche Group Afutuzumab Product Offerings
Table 56. Roche Group Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 57. Roche Group Key News & Latest Developments
Table 58. TargetMol Chemicals Company Summary
Table 59. TargetMol Chemicals Afutuzumab Product Offerings
Table 60. TargetMol Chemicals Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 61. TargetMol Chemicals Key News & Latest Developments
Table 62. Wonda Science Company Summary
Table 63. Wonda Science Afutuzumab Product Offerings
Table 64. Wonda Science Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 65. Wonda Science Key News & Latest Developments
Table 66. Absin Bioscience Company Summary
Table 67. Absin Bioscience Afutuzumab Product Offerings
Table 68. Absin Bioscience Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 69. Absin Bioscience Key News & Latest Developments
Table 70. Chunchuang (Wuhan) Technology Company Summary
Table 71. Chunchuang (Wuhan) Technology Afutuzumab Product Offerings
Table 72. Chunchuang (Wuhan) Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 73. Chunchuang (Wuhan) Technology Key News & Latest Developments
Table 74. Hubei Kele Fine Chemical Company Summary
Table 75. Hubei Kele Fine Chemical Afutuzumab Product Offerings
Table 76. Hubei Kele Fine Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 77. Hubei Kele Fine Chemical Key News & Latest Developments
Table 78. Jiangxi Ruiweier Biotechnology Company Summary
Table 79. Jiangxi Ruiweier Biotechnology Afutuzumab Product Offerings
Table 80. Jiangxi Ruiweier Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 81. Jiangxi Ruiweier Biotechnology Key News & Latest Developments
Table 82. Qingdao Jieshikang Biotechnology Company Summary
Table 83. Qingdao Jieshikang Biotechnology Afutuzumab Product Offerings
Table 84. Qingdao Jieshikang Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 85. Qingdao Jieshikang Biotechnology Key News & Latest Developments
Table 86. Shanghai Biochempartner Company Summary
Table 87. Shanghai Biochempartner Afutuzumab Product Offerings
Table 88. Shanghai Biochempartner Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 89. Shanghai Biochempartner Key News & Latest Developments
Table 90. Shanghai Macklin Biochemical Company Summary
Table 91. Shanghai Macklin Biochemical Afutuzumab Product Offerings
Table 92. Shanghai Macklin Biochemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 93. Shanghai Macklin Biochemical Key News & Latest Developments
Table 94. Shanghai Qiming Biotechnology Company Summary
Table 95. Shanghai Qiming Biotechnology Afutuzumab Product Offerings
Table 96. Shanghai Qiming Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 97. Shanghai Qiming Biotechnology Key News & Latest Developments
Table 98. Shanghai Saimai Biotechnology Company Summary
Table 99. Shanghai Saimai Biotechnology Afutuzumab Product Offerings
Table 100. Shanghai Saimai Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 101. Shanghai Saimai Biotechnology Key News & Latest Developments
Table 102. Shanghai Shize Biological Technology Company Summary
Table 103. Shanghai Shize Biological Technology Afutuzumab Product Offerings
Table 104. Shanghai Shize Biological Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 105. Shanghai Shize Biological Technology Key News & Latest Developments
Table 106. Shanghai Yifei Biotechnology Company Summary
Table 107. Shanghai Yifei Biotechnology Afutuzumab Product Offerings
Table 108. Shanghai Yifei Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 109. Shanghai Yifei Biotechnology Key News & Latest Developments
Table 110. Shanghai Yu'ang Chemical Company Summary
Table 111. Shanghai Yu'ang Chemical Afutuzumab Product Offerings
Table 112. Shanghai Yu'ang Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 113. Shanghai Yu'ang Chemical Key News & Latest Developments
Table 114. Tianmen Hengchang Chemical Company Summary
Table 115. Tianmen Hengchang Chemical Afutuzumab Product Offerings
Table 116. Tianmen Hengchang Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 117. Tianmen Hengchang Chemical Key News & Latest Developments
Table 118. Wuhan Sunrise Technology Development Company Summary
Table 119. Wuhan Sunrise Technology Development Afutuzumab Product Offerings
Table 120. Wuhan Sunrise Technology Development Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 121. Wuhan Sunrise Technology Development Key News & Latest Developments
Table 122. Wuhan Yingnuo Pharmaceutical Technology Company Summary
Table 123. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product Offerings
Table 124. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 125. Wuhan Yingnuo Pharmaceutical Technology Key News & Latest Developments
Table 126. Afutuzumab Capacity of Key Manufacturers in Global Market, 2023-2025 (Kg)
Table 127. Global Afutuzumab Capacity Market Share of Key Manufacturers, 2023-2025
Table 128. Global Afutuzumab Production by Region, 2020-2025 (Kg)
Table 129. Global Afutuzumab Production by Region, 2026-2032 (Kg)
Table 130. Afutuzumab Market Opportunities & Trends in Global Market
Table 131. Afutuzumab Market Drivers in Global Market
Table 132. Afutuzumab Market Restraints in Global Market
Table 133. Afutuzumab Raw Materials
Table 134. Afutuzumab Raw Materials Suppliers in Global Market
Table 135. Typical Afutuzumab Downstream
Table 136. Afutuzumab Downstream Clients in Global Market
Table 137. Afutuzumab Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Afutuzumab Product Picture
Figure 2. Afutuzumab Segment by Type in 2024
Figure 3. Afutuzumab Segment by Application in 2024
Figure 4. Global Afutuzumab Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Afutuzumab Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Afutuzumab Revenue: 2020-2032 (US$, Mn)
Figure 8. Afutuzumab Sales in Global Market: 2020-2032 (Kg)
Figure 9. The Top 3 and 5 Players Market Share by Afutuzumab Revenue in 2024
Figure 10. Segment by Type � Global Afutuzumab Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Afutuzumab Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Afutuzumab Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Afutuzumab Price (US$/Kg), 2020-2032
Figure 14. Segment by Application � Global Afutuzumab Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Afutuzumab Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Afutuzumab Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Afutuzumab Price (US$/Kg), 2020-2032
Figure 18. By Region � Global Afutuzumab Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Afutuzumab Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Afutuzumab Revenue Market Share, 2020-2032
Figure 21. By Region - Global Afutuzumab Sales Market Share, 2020-2032
Figure 22. By Country - North America Afutuzumab Revenue Market Share, 2020-2032
Figure 23. By Country - North America Afutuzumab Sales Market Share, 2020-2032
Figure 24. United States Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Afutuzumab Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Afutuzumab Sales Market Share, 2020-2032
Figure 29. Germany Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 30. France Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Afutuzumab Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Afutuzumab Sales Market Share, 2020-2032
Figure 38. China Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 42. India Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Afutuzumab Revenue Market Share, 2020-2032
Figure 44. By Country - South America Afutuzumab Sales, Market Share, 2020-2032
Figure 45. Brazil Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Afutuzumab Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Afutuzumab Sales, Market Share, 2020-2032
Figure 49. Turkey Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Afutuzumab Revenue, (US$, Mn), 2020-2032
Figure 53. Global Afutuzumab Production Capacity (Kg), 2020-2032
Figure 54. The Percentage of Production Afutuzumab by Region, 2024 VS 2032
Figure 55. Afutuzumab Industry Value Chain
Figure 56. Marketing Channels
